CS244148B2 - Method of aminomethylpyrrolidine production - Google Patents

Method of aminomethylpyrrolidine production Download PDF

Info

Publication number
CS244148B2
CS244148B2 CS851537A CS153784A CS244148B2 CS 244148 B2 CS244148 B2 CS 244148B2 CS 851537 A CS851537 A CS 851537A CS 153784 A CS153784 A CS 153784A CS 244148 B2 CS244148 B2 CS 244148B2
Authority
CS
Czechoslovakia
Prior art keywords
acid
mixture
mol
active
oder
Prior art date
Application number
CS851537A
Other languages
Czech (cs)
English (en)
Other versions
CS153784A2 (en
Inventor
Karl-Heinz Weber
Gerhard Walther
Claus Schneider
Dieter Hinzen
Franz J Kuhn
Erich Lehr
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of CS153784A2 publication Critical patent/CS153784A2/cs
Publication of CS244148B2 publication Critical patent/CS244148B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
CS851537A 1983-10-04 1984-10-03 Method of aminomethylpyrrolidine production CS244148B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833336024 DE3336024A1 (de) 1983-10-04 1983-10-04 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel

Publications (2)

Publication Number Publication Date
CS153784A2 CS153784A2 (en) 1985-08-15
CS244148B2 true CS244148B2 (en) 1986-07-17

Family

ID=6210932

Family Applications (2)

Application Number Title Priority Date Filing Date
CS851537A CS244148B2 (en) 1983-10-04 1984-10-03 Method of aminomethylpyrrolidine production
CS914108A CS410891A3 (en) 1983-10-04 1991-12-27 1-benzylaminoalkylpyrrolidinones, process of their preparation andpharmaceuticals containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
CS914108A CS410891A3 (en) 1983-10-04 1991-12-27 1-benzylaminoalkylpyrrolidinones, process of their preparation andpharmaceuticals containing them

Country Status (27)

Country Link
US (4) US4767759A (no)
EP (1) EP0136658B1 (no)
JP (2) JPS6094959A (no)
KR (1) KR910007882B1 (no)
AR (1) AR243503A1 (no)
AU (1) AU565839B2 (no)
CA (1) CA1242193A (no)
CS (2) CS244148B2 (no)
DD (1) DD227963A5 (no)
DE (2) DE3336024A1 (no)
DK (1) DK164049C (no)
ES (3) ES536469A0 (no)
FI (1) FI78464C (no)
GR (1) GR80546B (no)
HK (1) HK75892A (no)
HU (1) HU193229B (no)
IE (1) IE58155B1 (no)
IL (1) IL73125A (no)
NO (1) NO165239C (no)
NZ (1) NZ209759A (no)
PH (1) PH23764A (no)
PL (2) PL145637B1 (no)
PT (1) PT79306B (no)
SG (1) SG44192G (no)
SU (2) SU1373318A3 (no)
YU (2) YU43858B (no)
ZA (1) ZA847755B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326724A1 (de) * 1983-07-25 1985-02-07 Boehringer Ingelheim KG, 6507 Ingelheim In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
DE3420193A1 (de) * 1984-05-30 1985-12-05 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel
DE3634220A1 (de) * 1986-10-08 1988-04-14 Boehringer Ingelheim Kg Verwendung von 1-benzyl-aminoalkyl-pyrrolidinonen als antidepressiva
DE3706399A1 (de) * 1987-02-27 1988-09-08 Boehringer Ingelheim Kg Mittel mit antidepressiver wirkung
DE3864124D1 (de) * 1987-05-20 1991-09-12 Zambon Spa Isoxazole mit nootropischer wirkung.
US4772601A (en) * 1988-01-25 1988-09-20 Hoechst-Roussel Pharmaceuticals, Inc. 5-Substituted 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinones, pharmaceutical compositions and use
IE61631B1 (en) * 1988-05-20 1994-11-16 Zambon Spa Compounds with central analgesic activity, process for their preparation and pharmaceutical compositions containing them
CA2007732A1 (en) * 1989-01-17 1990-07-17 Gary L. Olson Cyclohexaneacetamide derivatives
IT1231477B (it) * 1989-07-12 1991-12-07 Sigma Tau Ind Farmaceuti (pirrolidin-2-one-1-il) acetammidi quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
US5066663A (en) * 1990-05-21 1991-11-19 Warner-Lambert Company Substituted-hetero-cyclopentanones and cyclopentenones and derivatives thereof acting at muscarinic receptors
JPH083023Y2 (ja) * 1991-05-21 1996-01-29 株式会社四国総合研究所 太陽電池モジュール用架台
US5538985A (en) * 1994-01-27 1996-07-23 Mitsui Toatsu Chemicals, Inc. Pyrrolidinone derivatives
WO1997036900A1 (en) * 1996-04-03 1997-10-09 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US6001835A (en) * 1996-04-03 1999-12-14 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
BR9709857A (pt) * 1996-06-21 2002-05-21 Syntroleum Corp processo e sistema de produção de gás de sìntese
PE17599A1 (es) 1996-07-09 1999-02-22 Syntroleum Corp Procedimiento para convertir gases a liquidos
US5969138A (en) * 1996-11-01 1999-10-19 Mitsui Chemicals, Inc. Pyrrolidinone derivatives
US5950732A (en) * 1997-04-02 1999-09-14 Syntroleum Corporation System and method for hydrate recovery
AU9690298A (en) 1997-10-10 1999-05-03 Syntroleum Corporation System and method for converting light hydrocarbons to heavier hydrocarbons withseparation of water into oxygen and hydrogen
WO2000051607A1 (en) 1999-03-02 2000-09-08 Merck & Co., Inc. 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity
US6489354B1 (en) 1999-03-02 2002-12-03 Merck & Co., Inc. 3-alkyl substituted pyrrolidine modulators of chemokine receptor activity
AU3389300A (en) 1999-03-02 2000-09-21 Merck & Co., Inc. Pyrrolidine modulators of chemokine receptor activity
US6794417B2 (en) 2002-06-19 2004-09-21 Syntroleum Corporation System and method for treatment of water and disposal of contaminants produced by converting lighter hydrocarbons into heavier hydrocarbon
ATE539077T1 (de) * 2003-09-03 2012-01-15 Pfizer Benzimidazolonverbindungen mit agonistischer wirkung am 5-ht4 rezeptor
GEP20094638B (en) 2004-06-15 2009-03-10 Pfizer Benzimidazolone carboxylic acid derivatives
GR1004905B (el) * 2004-07-14 2005-05-27 Ε.Ι.Ε. (Εθνικο Ιδρυμα Ερευνων) Καινοτομα αντιυπερτασικα προιοντα
FR2940609B1 (fr) * 2008-12-30 2011-05-06 Oreal Association de monosaccharides et d'agents desquamants et son utilisation en cosmetique

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133082A (en) * 1960-06-09 1964-05-12 Mead Johnson & Co 1-substituted-3-pyrrolidylmethylamines
NL136272C (no) * 1962-07-13
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
BE791606A (fr) * 1972-07-10 1973-03-16 Pilot Pen Co Ltd Procede et appareil pour aspirer et soulever la feuille la plussuperieure d'une pile de feuilles de ce type
JPS5244559A (en) * 1975-10-06 1977-04-07 Ise Electronics Corp Fluorescent display tube with luminescent diode
JPS5346966A (en) * 1976-10-06 1978-04-27 Teijin Ltd Lactamamines and their preparation
JPS5344559A (en) * 1976-10-06 1978-04-21 Teijin Ltd New urethanes and their preparation
FR2387218A1 (fr) * 1977-04-15 1978-11-10 Ile De France Nouveaux n-(1'-ethyl 2'-oxo 5'-pyrrolidinyl methyl) benzamides, leurs procedes de preparation et leur application comme modificateurs du comportement
AU518986B2 (en) * 1977-10-11 1981-10-29 Takeda Chemical Industries Ltd. Lactams
CU21107A3 (es) * 1978-02-10 1988-02-01 Hoffmann La Roche Pyrrolidines derivatives
CA1115212A (en) * 1978-02-10 1981-12-29 Emilio Kyburz Pyrrolidine derivatives
DE2924011C2 (de) * 1979-06-13 1982-04-08 A. Nattermann & Cie GmbH, 5000 Köln Pyrrolidin-(2)-on-(1)-ylessigsäure-2,6,-dimethylanilid, Verfahren zur Herstellung und Arzneimittel, welche diese Verbindung enthalten
DE2923975A1 (de) * 1979-06-13 1980-12-18 Nattermann A & Cie Pyrrolidinone, verfahren zu deren herstellung und diese enthaltende arzneimittel
CH657527A5 (de) * 1980-02-13 1986-09-15 Ciba Geigy Ag Verwendung von zentralnervoes-wirksamen verbindungen in einem mittel, welches zur verhinderung oder linderung von nebenwirkungen bestimmt ist.
CH646149A5 (de) * 1981-02-05 1984-11-15 Hoffmann La Roche Pyrrolidin-derivat.
EP0089900B1 (en) * 1982-03-24 1985-12-27 Prodes S.A. New n-((2-oxo-1-pyrrolidinyl)acetyl)piperazines, the methods of producing such new compounds and their salts as well as pharmaceutical preparations for therapeutic use containing these compounds or salts
FR2549053B1 (fr) * 1983-07-12 1985-12-27 Sanofi Sa Nouveaux derives de la pyrrolidine actifs sur le systeme nerveux central, leur procede de preparation, les medicaments en contenant
DE3326724A1 (de) * 1983-07-25 1985-02-07 Boehringer Ingelheim KG, 6507 Ingelheim In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
DE3420193A1 (de) * 1984-05-30 1985-12-05 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel

Also Published As

Publication number Publication date
US4767759A (en) 1988-08-30
EP0136658A2 (de) 1985-04-10
DE3477922D1 (en) 1989-06-01
ES8601878A1 (es) 1985-11-16
NZ209759A (en) 1989-04-26
PL249852A1 (en) 1985-09-10
CA1242193A (en) 1988-09-20
KR850003393A (ko) 1985-06-17
ES8601877A1 (es) 1985-11-16
ES8505652A1 (es) 1985-06-01
IL73125A0 (en) 1984-12-31
DK474684A (da) 1985-04-05
EP0136658A3 (no) 1985-06-05
DK164049B (da) 1992-05-04
PL253280A1 (en) 1986-02-11
SU1373318A3 (ru) 1988-02-07
YU43901B (en) 1989-12-31
ES539883A0 (es) 1985-11-16
CS153784A2 (en) 1985-08-15
PT79306B (de) 1986-11-13
NO843979L (no) 1985-04-09
US4996224A (en) 1991-02-26
DK474684D0 (da) 1984-10-03
YU43858B (en) 1989-12-31
JPH046684B2 (no) 1992-02-06
US5073671A (en) 1991-12-17
PT79306A (de) 1984-11-01
IE842519L (en) 1985-04-04
FI78464B (fi) 1989-04-28
AU565839B2 (en) 1987-10-01
SG44192G (en) 1992-09-04
AU3383484A (en) 1985-04-18
NO165239C (no) 1991-01-16
CS410891A3 (en) 1992-08-12
JPS6094959A (ja) 1985-05-28
ZA847755B (en) 1986-06-25
YU199086A (en) 1987-10-31
ES536469A0 (es) 1985-06-01
AR243503A1 (es) 1993-08-31
JPH04261152A (ja) 1992-09-17
NO165239B (no) 1990-10-08
DK164049C (da) 1992-09-28
FI78464C (fi) 1989-08-10
ES539884A0 (es) 1985-11-16
PL145630B1 (en) 1988-10-31
DD227963A5 (de) 1985-10-02
GR80546B (en) 1985-02-05
PL145637B1 (en) 1988-10-31
HUT35641A (en) 1985-07-29
HU193229B (en) 1987-08-28
YU169684A (en) 1987-10-31
JPH0739387B2 (ja) 1995-05-01
IL73125A (en) 1988-10-31
HK75892A (en) 1992-10-09
FI843856L (fi) 1985-04-05
US4833140A (en) 1989-05-23
KR910007882B1 (ko) 1991-10-04
FI843856A0 (fi) 1984-10-02
EP0136658B1 (de) 1989-04-26
SU1306472A3 (ru) 1987-04-23
DE3336024A1 (de) 1985-04-18
IE58155B1 (en) 1993-07-14
PH23764A (en) 1989-11-03

Similar Documents

Publication Publication Date Title
CS244148B2 (en) Method of aminomethylpyrrolidine production
JP2650537B2 (ja) 縮合複素環誘導体
DE60201859T2 (de) Pharmazeutische Verwendung von N-Carbamoylazol-Derivate
US5985326A (en) Method of producing a solid dispersion of a poorly water soluble drug
DE602005003365T2 (de) Pyrrolopyridinderivate und deren verwendung als crth2-antagonisten
US5563150A (en) Pyrrolo-pyridine derivatives
US5563152A (en) Pyrrolo-pyridine derivatives
DE69111138T2 (de) Heterocyclische Verbindungen mit antiemetischer und Migräne unterdrückender Wirkung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen.
JPH02104526A (ja) 高血圧症治療用組成物
DE69311165T2 (de) Kondensierte heterocyclische Ketonderivate, ihre Herstellung und ihre Verwendung
JPS6289679A (ja) ピペリジン誘導体
DE60022227T2 (de) 2-(1h-indol-3-yl)-2-oxo-acetamide mit antitumoraler wirkung
DE69515177T2 (de) Tetrahydropyridinylmethylderivate von pyrrolo[2,3-b]pyridine
CS261883B2 (en) Method of new substituted pyrrolidinones production
DE69031111T2 (de) Indolderivate
DE69329084T2 (de) Benzoxazepin-Derivate als Cholinesterase-Inhibitoren
JPH04266873A (ja) ピペリジン誘導体
DE69215482T2 (de) 2,2'-Alkylendiindolderivate, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und deren Verwendung als Ulcustherapeutikum
CS244447B2 (en) In position 1 substituted 4-hydroxymethylpyrrolidinones production method
DE2804519A1 (de) Oxadiazolopyrimidin-derivate
US3847923A (en) N-(1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carbonyloxy)succinimide and glutarimide
EP0065295A1 (de) Substituierte Tryptaminderivate von Thienyloxypropanolaminen, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen sowie ihre Verwendung
DE60010855T2 (de) Phenylsulphonylderivative als 5-ht rezeptorliganden
CH651554A5 (de) Schwefelhaltige isochinolinderivate, verfahren zur herstellung derselben und die diese verbindungen enthaltenden pharmazeutischen zubereitungen.
JPS6396187A (ja) インドローピラジノーベンゾジアゼピン誘導体